Tobacco-sourced carcinogen including benzopyrene (B[a]P) in lung cancer metastasis has not been fully reported. In this study, lung carcinoma A549 cell line was used to investigate the potential roles of tobacco-sourced B[a]P on cell metastasis and invasion and to assess its underlying mechanism. Effects of tobacco-sourced carcinogen on A549 cell proliferation, metastasis, and invasion were analyzed using MTT assay, Transwell assay, and scratch method, respectively. The effects of tobacco-sourced carcinogen on cytokines and chemokines secretion were detected using enzyme-linked immunosorbent assay. Moreover, correlation between inflammatory factor expression and cancer cell migration and invasion was assessed using siRNA-mediated gene silencing. Data showed that both B[a]P and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone either at high or low dose performed no significant difference on A549 cell proliferation with time increasing. 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone performed no significant difference on A549 cell migration and invasion while B[a]P significantly increased A549 cell migration and invasion compared to the control group (P < 0.05). Consequently, except for IL-6, IL-8, CCL-2, and CCL-3, secretions were significantly increased by B[a]P treatment compared to the control (P < 0.05). Furthermore, when CCL-2 and CCL-3 were silenced, the migrated and invasive A549 cells were significantly decreased compared to the control, respectively (P < 0.05), while silenced IL-8 drastically decreased the migrated and invasive cells compared to the control (P < 0.01). Taken together, this study illustrated that there may be significant correlation between smoking and lung cancer metastasis. B[a]P maybe an excellent contributor for lung cancer metastasis through up-regulating IL-8, CCL-2, and CCL-3 expression.
Introduction
Lung cancer remains to be one of the most common malignancies, which is well known for the easy metastasis to variety kinds of organs including clavicle lymph node, bone, liver and pleura, and other sites. [1] [2] [3] [4] Statistics show that morbidity and mortality for lung cancer are drastically increasing in recent years, especially among male persons. 5 Varieties of treatment methods including genetic therapy, surgery, and chemotherapy for lung cancer have been discussed a lot in previous papers. 6, 7 However, there is no radical cure method for lung cancer due to its complicate pathogen.
Increasing evidence presented that smoking is closely correlated to lung cancer development and reported that the long-term smokers who get lung cancer are far more than the non-smokers. 8, 9 More than 2500 kinds of harmful substances have been researched in tobacco, including the strong carcinogens of benzopyrene (B[a]P) or nitrosamine (4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, NNK). 10, 11 The carcinogenesis for lung cancer by tobacco smoke derived significant attentions on B[a]P and NNK in lung cancer development and progression, inducing the mutations of Ras genes or P53 via different signal pathways. 12, 13 For example, NNK-induced Kras mutation from
GGT to GAT at site 12 in human lung cancer tissue, 14 and B[a]P resulted in methylation of CpG on p16 and then enhanced P53 mutation in lung cancer progression. 15 However, few papers have reported the correlation between B[a]P in lung cancer metastasis. Chemokines are some gene-induced peptides which play crucial roles in tumor development, which are correlated to lung cancer cell growth, angiogenesis, and even metastasis. 16, 17 In addition to the genetic factors and environmental factors, literature refers that immunologic imbalance may also play pivotal roles in lung carcinoma. 18 Interleukin (IL)-8 is a multi-sourced cytokine which has been reported to be highly secreted in serum from lung cancer patients, as well as in para-carcinoma tissue. 19 Besides, CCL-2 and CCL-3 have been reported in several kinds of cancer's tumorigenesis and metastasis, including CCL2 is progressively up-regulated in prostate cancer and CCL3 promotes murine lung metastasis process through accumulating leukocytes and fibroblasts. 20, 21 Nonetheless, the effects of B[a]P in lung cancer metastasis and its mechanism still remain unknown.
In this study, we used human lung adenocarcinoma A549 cell line to investigate the potential effects of B[a]P and NNK on cell migration and invasion. Varieties of experimental methods were used to assess the effects of B[a]P and NNK on cytokines and chemokines secretion during cell migration and invasion. Additionally, the possible role of B[a]P in lung cancer metastasis was further verified in another lung cancer H1299 cell line. This study was aimed to investigate the potential roles of tobaccosourced carcinogens B[a]P on lung cancer metastasis and its possible mechanism.
Materials and methods

Cell culture and cell treatment
Human lung adenocarcinoma A549 and H1299 cell lines (purchased from Shanghai Bioleaf Bio Co., Ltd, Shanghai, China) were cultured in RPMI-1640 medium (Invitrogen, USA) containing 10% fetal bovine serum (FBS), 100 U/mL penicillin, 100 mg/mL streptomycin, and 1% L-glutamine (Sigma, USA) in an atmosphere of 5% CO 2 at 37 C. Cells were plated onto the six-well plates in 2 mL of fresh RPMI-1640 medium to adjust the cell density of 1 Â 10 5 cells/well. After 24 h of cultivation, cells were mixed with benzopyrene or nitrosamine (C 20 H 12 ; purity, > 96%; Sigma) for 24, 48, and 72 h. Each experiment was conducted three times independently.
MTT assay
A549 cells were plated onto the 96-well plates at a cell density of 5 Â 10 5 cells/well in 1 mL of fresh RPMI-1640 medium containing 10% FBS. After 24 h of incubation, benzopyrene or nitrosamine was added into each well and incubated for 48 h. Consequently, 20 mL of MTT was added into each well and then the cells were incubated for 4 h at 37 C. After that, 150 mL of dimethylsulfoxide was supplemented into each well to mix with cells for 10 min. Absorbance of cells in each well was observed at 570 nm under an absorption spectrophotometer (Olympus, Japan). All experiments were conducted independently for three times.
Enzyme-linked immunosorbent assay
After 24 or 48 h treatment of drugs, conditioned medium was collected for enzyme-linked immunosorbent assay (ELISA). Standard ELISA methods as described by the manufacturers were used to measure IL-6, IL-8, CCL-2, and CCL-3 protein concentrations.
Cell migration and invasion assay
Cell migration and invasion were conducted using Transwell migration chambers (8 mm pore size; USA); in addition, the membranes for the invasion assay were coated with a diluted extracellular matrix (ECM) (namely the Matrigel, which consists of the laminin and type IV collagen) solution (Sigma). Briefly, A549 (5 Â 10 4 cells/well) cells were seeded in the upper portion of a chamber with serum-free medium after transfection. Medium contained 10% FBS with or without B[a]p (or NNK), served as a chemoattractant in the lower chamber. After 24 or 48 h incubation at 37 C, non-invaded cells on the top of the membrane were scraped and removed by cotton swabs, and the invaded cells were fixed, stained with Diff-Quik staining, and then counted using light microscopy. The migration and invasion assay was repeated three times.
siRNA transfection siRNA-mediated gene silencing was used to investigate the effects of IL-8, CCL-2, and CCL-3 expression on A549 cell migration and invasion. In brief, three kinds of vectors (purchased from SantaCruz, siRNA specific for IL-8 (sc-39631), CCL-2 (sc-43913), and CCL-3 (sc-43933)) were transfected into the A549 cells or H1299 cells using Lipofectamine Õ RNAiMAX Transfection Reagent based on the manufacturers' protocol (Life Technologies, USA). Cells transfected with the siRNA without the target gene sequence were considered as controls. After 48 h of transfection, cells were prepared for further analysis.
Western blotting
Cells treated with drugs treatment in each group were lysed with radioimmunoprecipitation assay (Sangon Biotech) containing phenylmethanesufonyl fluoride and then were centrifuged at 12,000 rpm at 4 C for 5 min. 22 Supernatant was collected to determine the concentration of lysed proteins using bicinchoninic acid protein assay kit (Pierce, Rochford, IL). For Western blotting, 23 a total of 50 mg protein per lane was subjected onto a 10% sodium dodecylsulfatepolyacrylamide gel electrophoresis and then transferred onto a polyvinylidencefluoride membrane (Mippore). Membranes were blocked in tris-buffered saline tween supplemented with 5% non-fat milk for 1 h and subsequently incubated with primary antibodies (1:1000 for IL-6, IL-8, CCL-2, CCL-3, and 1:5000 for GAPDH) overnight at 4 C, followed by incubation with horseradish peroxidaselabeled goat anti-rat secondary antibody. The immunoreactive protein bands were developed by enhanced chemiluminescence, and the immunoreactive bands were analyzed by a densitometer. Phosphoglyceraldehyde dehydrogenase (GAPDH, Sigma) was considered as the internal control.
Statistical analysis
The results of multiple experiments are presented as the mean AE SD. Statistical analyses were performed using graph prism 5.0 statistical software (GraphPad Prism, San Diego, CA). The P-values were calculated using a one-way analysis of variance with the post-hoc test. P < 0.05 was considered as statistically significant.
Results
Effects of B[a]P or NNK on A549 cell viability
The effects of B[a]P or NNK on A549 cell proliferation were assessed using MTT assay (Figure 1) . The results showed that there were no significant differences among groups when cells were treated with B[a]P at different concentrations (from 0 nM to 10,000 nM) at 48 h (Figure 1(a) ). Similarly, no significant difference between the NNK at different concentration (from 0 to 5000 M) and the A549 cell viability at 48 h was observed (Figure 1(b) ), indicating that both B[a]P and NNK performed no significant effects on A549 cell viability at the early culture stage. Therefore, low dose of B[a]P and NNK on A549 cell viability with long time incubation were assessed to confirm whether the two kinds of drugs can influence A549 cell proliferation or not (Figure 1(c) ). Interestingly, there were no significant effects of low dose B[a]P or NNK on A549 cell viability at five days' incubation, indicating that both B[a]P and NNK would perform no significant effects on A549 cell viability.
Effects of B[a]P or NNK on A549 cell migration and invasion
Transwell and in vitro scratch assay were conducted to assess whether B[a]P or NNK could influence A549 cell migration and invasive or not (Figure 2 ). Transwell assay showed that when A549 cells were treated with high dose of B[a]P in long time incubation (1000 nM, 48 h), numbers of the migrated cells and the invaded cells were significantly increased compared to the control (P < 0.05, Figure 2 (a) to (c)); besides, the same tendency was observed in scratch assay (P < 0.05, Figure 2(d) ). However, the results presented that NKK treatment with high dose in long time incubation (500 M, 48 h) could not significantly influence A549 cell migration and invasion. On the other hand, effects of B[a]P or NNK with low dose on A549 cell migration and invasion were also assessed. When cells were treated with B[a]P (10 nM, 5 day), the number of migrated and invasive cells were statistically increased compared to the control (P < 0.05, Figure 2 (e) to (g)). However, no significant difference was found between NNK treatment and migrated or invasive A549 cells. These data indicate that B[a]P could significantly increase A549 cell migration and invasion, but NNK could not.
Effects of drug treatment on cytokine and chemokine secretion
Cytokines and chemokines secretion in A549 cells which were treated with B[a]P or NNK at low dose were analyzed ....................................................................................................................... using the Western blot and ELISA, respectively (Figure 3) . The results showed that secretions of IL-8, CCL-2, and CCL-3 in B[a]P-treated A549 cells were drastically increased compared to that in controls (P < 0.05, Figure 3 (a) and (b)) but no effects for B[a]P on IL-6 was found. In contrast to the influence of B[a]P on protein secretion in A549 cells, no significant difference between NNK treatment and proteins secretion was observed (Figure 3(a) and (b) ). These results suggested that there may be correlation between B[a]P treatment and cytokines and chemokines secretion in A549 cells except for NNK.
Effects of cytokine and chemokine silenced on A549 cell migration and invasion
In order to further verify whether the cytokine and chemokine levels were correlated with A549 cell migration and invasion, IL-8, CCL-2, and CCL-3 were silenced in B[a]Ptreated A549 cells using gene silencing (Figure 4 ). When cells were treated with B[a]P, the migrated and invasive cells were both significantly increased compared to the control, as well as the B[a]P-treated cells transfected with siRNA-control (P < 0.05, Figure 4(a) and (b) ). However, when cells were transfected with si-CLL-2 or si-CCL-3, in lung cancer metastasis 1519   .......................................................................................................................... cell migration and invasion ability were both statistically decreased compared to the B[a]P þ si-C group (P < 0.05, Figure 4 (a), (b), (d), and (e)). Besides, silenced IL-8 drastically decreased the migrated and invasive cells compared to the B[a]P þ si-C group (P < 0.01, Figure 4 (a) to (c)).
Influence of B[a]P on H1299 cell migration and invasion and the inflammatory factor secretion
In order to further verify the effects of B[a]P on lung cancer cell metastasis and invasion, another lung cancer H1299 cell was used to assess the effects of B[a]P on cell metastasis and inflammatory factors secretion ( Figure 5 ). The levels for IL-8, CCL-2, and CCL-3 in the B[a]P-treated H1299 cells were significantly increased compared to that in the control cells (P < 0.05, Figure 5(a) ). However, no significant difference was observed for the influence of NNK on the three kinds of cytokines secretion. Besides, the migrated and invaded H1299 cells were also increased by the B[a]P treatment ( Figure 5 
Discussion
It has been demonstrated that inflammatory factors such as cytokines and chemokines play crucial roles in lung cancer tumorigenesis. 16, 19 There are vast evidence about the harmful effects of tobacco-derived carcinogen in a variety of ....................................................................................................................... tumor developments, especially in lung cancer. 14, 15 However, little is known about the roles of tobacco-derived carcinogen on lung cancer metastasis and invasion. In this present study, we assessed the effects of tobacco-sourced B[a]P and NNK on human lung carcinoma A549 cell proliferation, metastasis, and invasion and on cytokines and chemokines secretion. Our data presented that both B[a]P and NNK had no significant effect on lung cancer cell growth, but B[a]P could significantly enhance cell migration and invasion, as well as increase IL-8, CCL2, and CCL3 secretion in A549 cells, suggesting that smoking may be a significant contributor in lung cancer.
Cancer metastasis and invasion is a result of variety of complicate factor interactions including inflammatory factors, enzymes and adhesion proteins, and other molecules.
24,25 B[a]P is a ubiquitous polycyclic aromatic hydrocarbon and potent carcinogen which exists in water, smoke, and air. 26 Increasing evidence have demonstrated the pivotal roles of B[a]P in lung tumorigenesis including induced p53 or Ras genes mutation by damaging DNA or changing amino code. 27, 28 However, little has been known about B[a]P in lung cancer metastasis and invasion. Ueng et al. 29 proved that the induction for B[a]P on lung tumor invasion and metastasis was suppressed by fibroblast growth factor-9. In this study, B[a]P at any concentration showed the approximate similar influence on A549 cell proliferation ability (Figure 1 ), suggesting its high carcinogenesis in lung cancer. Therefore, we further analyzed the roles of B[a]P application on lung metastasis and invasion. Our results showed that B[a]P application significantly increased migrated and invasive A549 cells compared to the control (Figure 2 ), indicating that B[a]P may be correlated to lung cancer metastasis.
On the other side, immune factors such as chemokines and cytokine have been illustrated in variety of diseases including cancers carcinogenesis. 16 For instance, CCL-9 and CCL-21 are the therapeutic targets for lung cancer because they are contributors in lung carcinogenesis and migration. 30, 31 CCL-2 and CCL-3 in lung metastasis have not been fully discussed. However, a recent study which was conducted by Kitamura et al. 32 demonstrated that CCL-2 had a therapeutic impact in breast cancer metastasis through enhancing several macrophages retention. Meanwhile, abundant evidence have referred the pivotal carcinogenesis of IL-8 in lung cancer. Podechard et al. 33 demonstrated that IL-8 secretion induced by the air-sourced B[a]P would lead to lung inflammation. The data in this study revealed that B[a]P application would significantly increase the expression levels of CCL-2, CCL-3, and IL-8 in A549 cells (Figure 3 ), suggesting that B[a]P may contribute the inflammatory factors secretion in lung cancer metastasis. In order to further verify this result, we silenced the three factors of CCL-2, CCL-3, and IL-8 to assess the number of migrated and invasive A549 cells. Interestingly, the results tell us that the migrated and invasive A549 cells were less when CCL-2 and CCL-3 were silenced, and when IL-8 was silenced, the migrated cells were drastically decreased (Figure 4) , implying that the three kinds of inflammatory factors may involve in lung cancer metastasis and invasion. From another point of view, we also assessed the influences of B[a]P on lung cancer metastasis in another lung cancer cell line of H1299. Similar to that in A549 cells, the inflammatory factors secretion including CCL-2, CCL-3, and IL-8 was increased by B[a]P in H1299 cells, as well as the increasing impact for B[a]P on H1299 migration and invasion ( Figure 5 ), indicating that except for A549 cells, B[a]P treatment could also affect the migration and invasion by affecting the inflammatory cytokines secretion. These data revealed that the influence of B[a]P on lung cancer metastasis was not a specific action.
In conclusion, this study suggests that the tobaccosourced carcinogen B[a]P may play crucial roles in accelerating lung cancer metastasis through up-regulating the cytokine IL-8 and chemokine CCL-2 and CCL-3 expression. Our study may provide a basis for illustrating the correlation between smoking and lung cancer metastasis and may explain the therapeutic impact of cytokines and chemokines in metastasis of lung cancer. Further studies are still needed to confirm the deep regulating mechanism of cytokine and chemokine secretion on the metastasis of lung cancer at the transcriptional level.
